Cleveland Clinic Cancer Advances
Biomarkers Predict Outcomes of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma
24 Feb 2022
Description
Brian Hill, MD, PhD, Director of the Lymphoid Malignancies Program joins the Cancer Advances podcast to discuss research and findings that were presented at the 2021 American Society of Hematology Annual Meeting (ASH). Listen as Dr. Hill discusses how CAR T-Cell therapy may be a lifesaving option for patients with relapsed or refractory disease.
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster